Studies and latest insights
How the chemical and pharmaceutical industry is responding to the Brexit vote
For the study in July and August this year, CAMELOT Management Consultants surveyed 200 key decision-makers in the chemical and pharmaceutical industries in Germany.
PHARMA Management Radar: Differentiated Supply Chains
Life Sciences companies are currently impacted by various trends that increase the complexity of their business, particularly in the supply chain area. The differentiation of supply chains might be a way out of the complexity trap. But what does the pharmaceutical industry think about this? Are differentiated supply chains seen as a suitable approach to master complexity?
Supply Chain Organization in Discrete Manufacturing Industries
The organization of the supply chain becomes an increasingly important key factor for a company´s future success. Nevertheless, little has been written about how companies have set up their supply chain organizations and the rationale behind their design choices.
The Top Transformations in the Chemical Industry
As a response to increasing turbulence and volatility on buying and selling markets, companies in the chemical industry are reviewing their business strategy inducing transformation and restructuring. The study examines the question what transformations turn out successful and what essentially leads to this success.
White Paper: Demand Driven LEAN Supply Chain Planning
In recent years supply chain management (SCM) requirements have changed significantly in the Consumer Product Goods (CPG) sector. The buzzword nowadays when managing global supply chains is adaptation to increasing global complexity and volatility.
Market Report: The Pharmaceutical Market in the Gulf Region – Supply Chain Outlook to the Future
With a projected annual growth rate of 9.2% by 2020 the Gulf Countries are one of the fastest growing pharma markets in the world. However, the local pharmaceutical industry in the Gulf region is at a crossroads: limited workforce resources, changing regulations as well as limited research and innovative products capabilities are just a few issues the industry is battling.
Chemical Industry Trend Survey CHEMonitor no. 26 – Feedstock Procurement
Industry survey in the chemical industry shows decreasing satisfaction with site conditions in Germany.
Chemical Industry Study: Operations Excellence 4.0
In many companies, operations strategy is confined to production, an overarching operations strategy rarely exists. "Internet of things" and digitization will have a strong innovative impact on operations strategies and operational excellence initiatives.
PHARMA Management Radar: „Internet Of Things“ Will Not Make A Breakthrough Until 2030
Although many Life Science companies have implemented or planned „Internet of Things“ (IoT) projects, and some technologies already play an important role, the real breakthrough of IoT is not expected to happen until 2013.
PHARMA Management Radar on Pharma Logistics : Beyond the pill service – are you ready?
The executives’ view of the business climate for the pharmaceutical industry has remained as positive as it had been one year earlier. New services offered 'beyond the pill" will impact logistics substantially.
Focus Topics Chemicals: Global Game Changers and Strategic Options
According to the current CheMonitor panel study by Camelot, the majority of European chemicals companies are expecting a positive economic climate and are highly satisfied with local conditions. The reasons for this include the weak euro, the development of the oil price and, in part, the robust demand from the domestic market. This snapshot does however obscure the fact that the global chemicals industry is undergoing significant changes.
Chemical Industry 2014: Management Agenda for Profitable Growth
The Camelot Focus Topic Paper Chemicals 2014 is about the following subjects: top-line improvement in agro and functional chemicals, transformation of a base chemicals business, sourcing in petrochemicals and Polymers and working capital optimization within specialty chemicals.
PHARMA Management Radar: Global Pharmaceutical companies expect hard price competition in the rising Biosimilars segment
Business climate in the next 12 months has brightened up, especially among Innovators – Japan and the US seem to come back in terms of demand growth. Two thirds of the Generics and almost 40% of the Innovators name the impact of Biosimilars as most important industry trend.
Finding and optimally managing suppliers – a study by Camelot Management Consultants on Strategic Supplier Management
Study shows great progress in the quality of supplier products, transparency, delivery periods and reliability of supply through professional Supplier Management.
SCM Organisation Study – Challenges & performance drivers for supply chain / operations organisations
Supply chain organisations need to engage better with stakeholders and participate actively in the development of supply chain strategy.
Launch Excellence in the “Outcome Era” – Changes, challenges and success factors
Gain insights into current changes of the process of launching novel drugs in the Outcome Era. Understand the industry's awareness of current changes and their expectations of future changes.
PHARMA Management Radar: Global Pharmaceutical companies worry most about Regulation and Product Supply Reliability
Top trend for Generics segment is increased reliability of product supply through risk management, Innovators mainly strive for successful product launches.
Strategic Management of Master Data Quality
More than half of the companies questioned indicate that insufficient master data still has a massive negative effect on the processes along the end-to-end value chain.
Chemical Industry 2013: Ensure your value chains are agile in volatile times
Over the last couple of years, the volatile business environment has dominated discussions around forecasts and business outlook in the chemical industry.
Drug Supply 2.0: Study by ESB Business School and Camelot Management Consultants on how to manage a disaggregated pharmaceutical supply chain
Dramatic regional shift: “Pharmerging markets” will outpace the traditional markets in terms of market growth by 2013 and change the rules of the industry
The postponed revolution – The dynamics of change in digital marketing (German)
Digital marketing initiatives are seldom strategically planned, and over a third of the companies still predominantly use standard forms of communication such as the Internet, e-mail or search functions.
Strategic Master Data Management
Leveraging efficient business processes: Why strategic master data management has reached the executive agenda
White Paper: Pharma Logistiscs in Asia
Camelot's White Paper describes in detail the Free Trade Zones (FTZ) concept and provides pharma companies with well-grounded decision-making support when choosing an FTZ.
Camelot PHARMA Management Radar on Contract Manufacturing Outsourcing (CMO)
Despite a positive assessment of the current business climate and an increasing number of products in the pipeline, the global pharmaceutical industry is continuously cutting costs using contract manufacturing organizations (CMOs).
Blackbox Digital Marketing: Most Companies fail to measure the success of their social media activities
Efficient Social Media Marketing requires a qualification offensive and investments in instruments, processes and Software tools.
Mastering Complexity in Transportation Management
Study by Camelot Management Consultants and Duale Hochschule Baden-Württemberg analyzes the logistics status quo and defines the optimal setup for a modern holistic transport management strategyTransportation has become a critical bottleneck in supply chains due to globalization, M&A and increasing customer expectations.
Enterprise Process & Information Governance – Integration of process and master data governance as competitive advantage
Survey of around 70 companies from a variety of industries and different sizes about the current state of governance in the areas of BPM and MDM and its integration
White Paper: Cyclic transportation planning in process industries
Supply chains become increasingly complex – with risks of delays and contingency risks soaring. This conflicts with efficient day-to-day transportation management.
PHARMA Management Radar on “VUCA challenges”
Global pharmaceutical supply chain heads see organizational issues as biggest hurdles for successful implementation of countermeasures.
Study “Mastering Complexity”: Most European companies are afraid of losing control over rising complexity
83% of participants state that the current level of complexity at their company is too high. 76% say they expect complexity to increase even further.